APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mosapride Citrate Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Mosapride Citrate Tablets Market Outlook and Growth Opportunities 2026

29 December 2025195 pages

Choose your research edition.

Industry ResearchMosapride Citrate Tablets Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Mosapride Citrate Tablets Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Mosapride Citrate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mosapride Citrate Tablets Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Mosapride Citrate Tablets Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Mosapride Citrate Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Mosapride Citrate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mosapride Citrate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mosapride Citrate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Mosapride Citrate Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Mosapride Citrate Tablets market include Yabao Pharmaceutical Group Co., Ltd., Lunan Beite Pharmaceutical Co., Ltd., Jiangsu Hausen Pharmaceutical Group Co., Ltd., Guangdong Annuo Pharmaceutical Co., Ltd., Chengdu Kanghong Pharmaceutical Group Co., Ltd. and Sumitomo Pharma Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Mosapride Citrate Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mosapride Citrate Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mosapride Citrate Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mosapride Citrate Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Mosapride Citrate Tablets Segment by Company

Yabao Pharmaceutical Group Co., Ltd.

Lunan Beite Pharmaceutical Co., Ltd.

Jiangsu Hausen Pharmaceutical Group Co., Ltd.

Guangdong Annuo Pharmaceutical Co., Ltd.

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Sumitomo Pharma Co., Ltd.

Mosapride Citrate Tablets Segment by Type

Original Drug

Generic Drug

Mosapride Citrate Tablets Segment by Application

Online Sales

Offline Sales

Mosapride Citrate Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Mosapride Citrate Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Mosapride Citrate Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mosapride Citrate Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Mosapride Citrate Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mosapride Citrate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mosapride Citrate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mosapride Citrate Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mosapride Citrate Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mosapride Citrate Tablets industry.

Chapter 3: Detailed analysis of Mosapride Citrate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Mosapride Citrate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Mosapride Citrate Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mosapride Citrate Tablets Industry Trends Table 2. Mosapride Citrate Tablets Industry Drivers Table 3. Mosapride Citrate Tablets Industry Opportunities and Challenges Table 4. Mosapride Citrate Tablets Industry Restraints Table 5. Global Mosapride Citrate Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mosapride Citrate Tablets Revenue Share by Company (2021-2026) Table 7. Global Mosapride Citrate Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Mosapride Citrate Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Mosapride Citrate Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Mosapride Citrate Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Mosapride Citrate Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Mosapride Citrate Tablets Company, Product Type & Application Table 13. Global Mosapride Citrate Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Mosapride Citrate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Original Drug Table 18. Significant Companies of Generic Drug Table 19. Global Mosapride Citrate Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Mosapride Citrate Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Mosapride Citrate Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Mosapride Citrate Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Mosapride Citrate Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Mosapride Citrate Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Mosapride Citrate Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Mosapride Citrate Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Mosapride Citrate Tablets Sales Value Share by Type (2021-2026) Table 28. Global Mosapride Citrate Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Online Sales Table 30. Significant Companies of Offline Sales Table 31. Global Mosapride Citrate Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Mosapride Citrate Tablets Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Mosapride Citrate Tablets Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Mosapride Citrate Tablets Sales Volume Share by Application (2021-2026) Table 35. Global Mosapride Citrate Tablets Sales Volume Share by Application (2027-2032) Table 36. Global Mosapride Citrate Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Mosapride Citrate Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Mosapride Citrate Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Mosapride Citrate Tablets Sales Value Share by Application (2021-2026) Table 40. Global Mosapride Citrate Tablets Sales Value Share by Application (2027-2032) Table 41. Global Mosapride Citrate Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Mosapride Citrate Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Mosapride Citrate Tablets Sales Market Share by Region (2021-2026) Table 44. Global Mosapride Citrate Tablets Sales by Region (2027-2032) & (K Units) Table 45. Global Mosapride Citrate Tablets Sales Market Share by Region (2027-2032) Table 46. Global Mosapride Citrate Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Mosapride Citrate Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Mosapride Citrate Tablets Sales Value Share by Region (2021-2026) Table 49. Global Mosapride Citrate Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Mosapride Citrate Tablets Sales Value Share by Region (2027-2032) Table 51. Global Mosapride Citrate Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Mosapride Citrate Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Mosapride Citrate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Mosapride Citrate Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Mosapride Citrate Tablets Sales by Country (2021-2026) & (K Units) Table 56. Global Mosapride Citrate Tablets Sales Market Share by Country (2021-2026) Table 57. Global Mosapride Citrate Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Mosapride Citrate Tablets Sales Market Share by Country (2027-2032) Table 59. Global Mosapride Citrate Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Mosapride Citrate Tablets Sales Value Market Share by Country (2021-2026) Table 61. Global Mosapride Citrate Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Mosapride Citrate Tablets Sales Value Market Share by Country (2027-2032) Table 63. Yabao Pharmaceutical Group Co., Ltd. Company Information Table 64. Yabao Pharmaceutical Group Co., Ltd. Business Overview Table 65. Yabao Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Yabao Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Product Portfolio Table 67. Yabao Pharmaceutical Group Co., Ltd. Recent Development Table 68. Lunan Beite Pharmaceutical Co., Ltd. Company Information Table 69. Lunan Beite Pharmaceutical Co., Ltd. Business Overview Table 70. Lunan Beite Pharmaceutical Co., Ltd. Mosapride Citrate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Lunan Beite Pharmaceutical Co., Ltd. Mosapride Citrate Tablets Product Portfolio Table 72. Lunan Beite Pharmaceutical Co., Ltd. Recent Development Table 73. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information Table 74. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview Table 75. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Product Portfolio Table 77. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Development Table 78. Guangdong Annuo Pharmaceutical Co., Ltd. Company Information Table 79. Guangdong Annuo Pharmaceutical Co., Ltd. Business Overview Table 80. Guangdong Annuo Pharmaceutical Co., Ltd. Mosapride Citrate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Guangdong Annuo Pharmaceutical Co., Ltd. Mosapride Citrate Tablets Product Portfolio Table 82. Guangdong Annuo Pharmaceutical Co., Ltd. Recent Development Table 83. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Company Information Table 84. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Business Overview Table 85. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Product Portfolio Table 87. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Recent Development Table 88. Sumitomo Pharma Co., Ltd. Company Information Table 89. Sumitomo Pharma Co., Ltd. Business Overview Table 90. Sumitomo Pharma Co., Ltd. Mosapride Citrate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sumitomo Pharma Co., Ltd. Mosapride Citrate Tablets Product Portfolio Table 92. Sumitomo Pharma Co., Ltd. Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Mosapride Citrate Tablets Distributors List Table 96. Mosapride Citrate Tablets Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Mosapride Citrate Tablets Product Image Figure 2. Global Mosapride Citrate Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mosapride Citrate Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Mosapride Citrate Tablets Sales (2021-2032) & (K Units) Figure 5. Global Mosapride Citrate Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Mosapride Citrate Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Original Drug Image Figure 10. Generic Drug Image Figure 11. Global Mosapride Citrate Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Mosapride Citrate Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Mosapride Citrate Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Mosapride Citrate Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Mosapride Citrate Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Mosapride Citrate Tablets Sales Value Share by Type (2021-2032) Figure 17. Online Sales Image Figure 18. Offline Sales Image Figure 19. Global Mosapride Citrate Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Mosapride Citrate Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Mosapride Citrate Tablets Sales Volume Share by Application (2021-2032) Figure 22. Global Mosapride Citrate Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Mosapride Citrate Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Mosapride Citrate Tablets Sales Value Share by Application (2021-2032) Figure 25. Global Mosapride Citrate Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Mosapride Citrate Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Mosapride Citrate Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Mosapride Citrate Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Mosapride Citrate Tablets Sales Value (2021-2032) & (US$ Million) Figure 30. North America Mosapride Citrate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Mosapride Citrate Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Mosapride Citrate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Mosapride Citrate Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Mosapride Citrate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Mosapride Citrate Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. South America Mosapride Citrate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Mosapride Citrate Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Mosapride Citrate Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Mosapride Citrate Tablets Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Mosapride Citrate Tablets Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Yabao Pharmaceutical Group Co., Ltd.
  • Lunan Beite Pharmaceutical Co., Ltd.
  • Jiangsu Hausen Pharmaceutical Group Co., Ltd.
  • Guangdong Annuo Pharmaceutical Co., Ltd.
  • Chengdu Kanghong Pharmaceutical Group Co., Ltd.
  • Sumitomo Pharma Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mosapride Citrate Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Mosapride Citrate Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Mosapride Citrate Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Mosapride Citrate Tablets Market Dynamics
  1. 2.1 Mosapride Citrate Tablets Industry Trends
  2. 2.2 Mosapride Citrate Tablets Industry Drivers
  3. 2.3 Mosapride Citrate Tablets Industry Opportunities and Challenges
  4. 2.4 Mosapride Citrate Tablets Industry Restraints
3 Mosapride Citrate Tablets Market by Company
  1. 3.1 Global Mosapride Citrate Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Mosapride Citrate Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Mosapride Citrate Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Mosapride Citrate Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Mosapride Citrate Tablets Company Ranking (2024-2026)
  6. 3.6 Global Mosapride Citrate Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Mosapride Citrate Tablets Company Product Type and Application
  8. 3.8 Global Mosapride Citrate Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Mosapride Citrate Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Mosapride Citrate Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Mosapride Citrate Tablets Market by Type
  1. 4.1 Mosapride Citrate Tablets Type Introduction
  2. 4.1.1 Original Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Mosapride Citrate Tablets Sales Volume by Type
  5. 4.2.1 Global Mosapride Citrate Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Mosapride Citrate Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Mosapride Citrate Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Mosapride Citrate Tablets Sales Value by Type
  9. 4.3.1 Global Mosapride Citrate Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Mosapride Citrate Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Mosapride Citrate Tablets Sales Value Share by Type (2021-2032)
5 Mosapride Citrate Tablets Market by Application
  1. 5.1 Mosapride Citrate Tablets Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Mosapride Citrate Tablets Sales Volume by Application
  5. 5.2.1 Global Mosapride Citrate Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Mosapride Citrate Tablets Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Mosapride Citrate Tablets Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Mosapride Citrate Tablets Sales Value by Application
  9. 5.3.1 Global Mosapride Citrate Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Mosapride Citrate Tablets Sales Value by Application (2021-2032)
  11. 5.3.3 Global Mosapride Citrate Tablets Sales Value Share by Application (2021-2032)
6 Mosapride Citrate Tablets Regional Sales and Value Analysis
  1. 6.1 Global Mosapride Citrate Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mosapride Citrate Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Mosapride Citrate Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Mosapride Citrate Tablets Sales by Region (2027-2032)
  5. 6.3 Global Mosapride Citrate Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Mosapride Citrate Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Mosapride Citrate Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Mosapride Citrate Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Mosapride Citrate Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Mosapride Citrate Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Mosapride Citrate Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Mosapride Citrate Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Mosapride Citrate Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Mosapride Citrate Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Mosapride Citrate Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Mosapride Citrate Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Mosapride Citrate Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Mosapride Citrate Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Mosapride Citrate Tablets Sales Value Share by Country, 2025 VS 2032
7 Mosapride Citrate Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Mosapride Citrate Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mosapride Citrate Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Mosapride Citrate Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Mosapride Citrate Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Mosapride Citrate Tablets Sales by Country (2027-2032)
  6. 7.4 Global Mosapride Citrate Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Mosapride Citrate Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Mosapride Citrate Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Mosapride Citrate Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Mosapride Citrate Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Mosapride Citrate Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yabao Pharmaceutical Group Co., Ltd.
  2. 8.1.1 Yabao Pharmaceutical Group Co., Ltd. Company Information
  3. 8.1.2 Yabao Pharmaceutical Group Co., Ltd. Business Overview
  4. 8.1.3 Yabao Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yabao Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Product Portfolio
  6. 8.1.5 Yabao Pharmaceutical Group Co., Ltd. Recent Developments
  7. 8.2 Lunan Beite Pharmaceutical Co., Ltd.
  8. 8.2.1 Lunan Beite Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Lunan Beite Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Lunan Beite Pharmaceutical Co., Ltd. Mosapride Citrate Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Lunan Beite Pharmaceutical Co., Ltd. Mosapride Citrate Tablets Product Portfolio
  12. 8.2.5 Lunan Beite Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Jiangsu Hausen Pharmaceutical Group Co., Ltd.
  14. 8.3.1 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information
  15. 8.3.2 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview
  16. 8.3.3 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Product Portfolio
  18. 8.3.5 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments
  19. 8.4 Guangdong Annuo Pharmaceutical Co., Ltd.
  20. 8.4.1 Guangdong Annuo Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Guangdong Annuo Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Guangdong Annuo Pharmaceutical Co., Ltd. Mosapride Citrate Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Guangdong Annuo Pharmaceutical Co., Ltd. Mosapride Citrate Tablets Product Portfolio
  24. 8.4.5 Guangdong Annuo Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Chengdu Kanghong Pharmaceutical Group Co., Ltd.
  26. 8.5.1 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Company Information
  27. 8.5.2 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Business Overview
  28. 8.5.3 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Product Portfolio
  30. 8.5.5 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Recent Developments
  31. 8.6 Sumitomo Pharma Co., Ltd.
  32. 8.6.1 Sumitomo Pharma Co., Ltd. Company Information
  33. 8.6.2 Sumitomo Pharma Co., Ltd. Business Overview
  34. 8.6.3 Sumitomo Pharma Co., Ltd. Mosapride Citrate Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sumitomo Pharma Co., Ltd. Mosapride Citrate Tablets Product Portfolio
  36. 8.6.5 Sumitomo Pharma Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mosapride Citrate Tablets Value Chain Analysis
  2. 9.1.1 Mosapride Citrate Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mosapride Citrate Tablets Sales Mode & Process
  6. 9.2 Mosapride Citrate Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mosapride Citrate Tablets Distributors
  9. 9.2.3 Mosapride Citrate Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst